NDC product
Pancreas DB Liquescence 3037
NDC 63083-3037 · Professional Complementary Health Formulas
Key facts
| Product NDC | 63083-3037 |
|---|---|
| Proprietary name | Pancreas DB Liquescence |
| Nonproprietary name | Pancreas DB Liquescence |
| Substances | TRILLIUM ERECTUM ROOT, FENUGREEK SEED, GYMNEMA SYLVESTRE LEAF, PHOSPHORIC ACID, RHUS AROMATICA ROOT BARK, SYZYGIUM CUMINI SEED, SILVER NITRATE, CHIONANTHUS VIRGINICUS BARK, PHOSPHORUS, ZINC, BOS TAURUS PANCREAS, CHROMIUM and 6 more |
| Dosage form | LIQUID |
| Route | ORAL |
| Labeler | Professional Complementary Health Formulas |
| Product type | HUMAN OTC DRUG |
| Marketing category | UNAPPROVED HOMEOPATHIC |
| Pharmacologic classes | Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Insulin Analog [EPC], Insulin [Chemical/Ingredient], Standardized Chemical Allergen [EPC] |
| Marketing start | Aug 15, 1984 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: